文献速递瓣膜外科

外科与经导管主动脉瓣置换术后长期再入院比较

Long-term Hospital Readmissions After Surgical Vs Transcatheter Aortic Valve Replacement.
PubMed 文献 · Ann Thorac Surg · 2019-04-27

单中心回顾性研究纳入2011至2017年2379例孤立SAVR或TAVR患者,TAVR组年龄更大、STS预测死亡风险更高。尽管两组30天、1年和5年总体再入院风险无差异,TAVR组5年心脏原因再入院率显著更高,心力衰竭为最常见原因。

要点

  • TAVR组5年心脏原因再入院率73.3%,高于SAVR组60.0%。
  • 心力衰竭是TAVR组心脏再入院最常见原因(58.7% vs 42.1%)。
  • 两组30天、1年和5年总体再入院风险无显著差异。

核心结论

  • TAVR术后长期心脏原因再入院率不成比例地高,其中心力衰竭最常见。
  • 这些数据可能支持对TAVR患者进行积极的医疗管理和仔细随访。

研究设计与样本

  • 单中心回顾性研究,纳入2011至2017年接受孤立SAVR和TAVR的患者。
  • 共纳入2379例患者,其中TAVR 1034例(43.5%),SAVR 1345例(56.5%)。
  • 主要结局为5年医院再入院,采用多变量logistic回归评估风险校正后TAVR与SAVR的影响。

主要发现

  • TAVR组平均年龄81.8 ± 7.8岁,SAVR组69.1 ± 11.85岁,P < .0001。
  • TAVR组STS预测死亡风险7.96% ± 4.71%,SAVR组2.73% ± 2.93%,P < .0001。
  • TAVR组手术死亡率3.19%,SAVR组1.12%,P < .004,风险校正后5年仍较高。
  • TAVR组5年心脏再入院率73.3%,SAVR组60.0%,P < .0001。
  • TAVR组心脏再入院中心力衰竭占58.7%,SAVR组42.1%,P = .0001。

临床怎么用

  • TAVR术后应加强心力衰竭的医疗管理和长期随访。
  • 尽管总体再入院风险无差异,需关注TAVR患者心脏原因再入院的长期风险。

局限性

  • 单中心回顾性研究,结果可能受中心经验和患者选择影响。
  • TAVR组年龄更大、合并症更多、STS预测死亡风险更高,存在基线差异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Limited data exist for rates and causes of readmission beyond short-term follow-up for patients undergoing surgical and transcatheter aortic valve replacement (SAVR and TAVR) METHODS: Patients undergoing isolated SAVR and TAVR between 2011 and 2017 at our institution were included in this study. The primary outcome was 5-year hospital readmission. The readmission cohort was identified from index readmission. Multivariable logistic regression analysis was used to evaluate the risk-adjusted impact of TAVR vs SAVR on outcomes. RESULTS: A total of 2379 patients were included: 1034 TAVR (43.5%) and 1345 SAVR (56.5%). Patients undergoing TAVR were on average older (81.8 ± 7.8 years vs 69.1 ± 11.85 years, P < .0001) and had more comorbidities than SAVR patients as represented by a greater Society of Thoracic Surgeons Predicted Risk of Mortality (7.96% ± 4.71% vs 2.73% ± 2.93%, P < .0001). Operative mortality was higher in the TAVR cohort (3.19% vs 1.12%, P < .004) and remained high at 5 years despite risk adjustment. Significantly more cardiac readmissions were found at 5-year follow-up in the TAVR group (73.3% vs 60.0%, P < .0001). Heart failure was the most common cause of cardiac readmission in the TAVR cohort (58.7% vs 42.1%, P = .0001). No difference was found in overall readmission risk at 30 days (hazard ratio [HR] 1.23, 95% confidence interval [CI]: 0.94 to 1.61, P = .12), 1 year (HR 0.93, 95% CI: 0.77 to 1.16, P = .52), and 5 years (HR 0.99, 95% CI: 0.83 to 1.18, P = .89). CONCLUSIONS: There is a disproportionately high rate of long-term hospital readmissions for cardiac causes, including heart failure, in patients who underwent TAVR. These data may support aggressive medical management of patients with careful follow-up in patients undergoing TAVR.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Bianco V, Kilic A, Gleason TG, et al. Long-term Hospital Readmissions After Surgical Vs Transcatheter Aortic Valve Replacement. Ann Thorac Surg. 2019. PMID: 31039354. doi:10.1016/j.athoracsur.2019.03.077

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。